Moderna (MRNA) Earnings: RSV Vaccine and Cancer Trial Data in Focus
As seen on the 24/7 Wall St. homepage on July 31, 2026.
Moderna reports before the bell with its RSV vaccine sales and personalized mRNA cancer trial data front and center for investors betting on the next growth driver beyond covid boosters.
Continue ReadingShow less
Moderna is set to report results before the opening bell on July 31, and the numbers investors care most about go well beyond the covid booster business that built the company. RSV vaccine sales will be closely watched as a signal of whether Moderna can carve out meaningful market share in a respiratory virus category already contested by larger rivals.
Equally important is any update on Moderna's personalized mRNA cancer vaccine program, which has drawn significant investor attention as a potential long-term growth engine. Progress data from ongoing trials could meaningfully shift how the market values the pipeline, making this report about far more than a single quarter's revenue figure.
Disclosure
1 INVESTMENTS ARE NOT FDIC INSURED • ARE NOT BANK GUARANTEED • MAY LOSE VALUE Brokerage and Active investing products offered through SoFi Securities LLC, member FINRA( www.finra.org )/SIPC( www.sipc.org ).2The probability of a member receiving $1,000 is 0.028%. If you don’t make a selection in 45 days, you’ll no longer qualify for the promo. Members must fund their account with a minimum of $50.00 to qualify. The probability percentage is subject to decrease. Members are only eligible for the Stock Award promotion upon opening their first brokerage account; subsequent cash brokerage accounts are ineligible for the promo, including for members with multiple accounts. 3Other fees, such as exchange fees, may apply. Please view our fee disclosure to view a full listing of fees. 4There are limitations with fractional shares to consider before investing. During market hours fractional share orders are transmitted immediately in the order received. There may be system delays from receipt of your order until execution and market conditions may adversely impact execution prices. Outside of market hours orders are received on a not held basis and will be aggregated for each security then executed in the morning trade window of the next business day at market open. Share will be delivered at an average price received for executing the securities through a single batched order. Fractional shares may not be transferred to another firm. Fractional shares will be sold when a transfer or closure request is initiated. Please consider that selling securities is a taxable event.
SoFi Active Invest is offering a limited-time promotion. Open an account, fund it with $50 or more, and you could receive up to $1,000 in complimentary stock for Active Invest accounts. See for yourself by clicking here now. (Sponsor)
With the confirmed pre-market release time and no specific hour disclosed, traders should expect results and any accompanying commentary to land before U.S. equities open, setting the tone for MRNA shares at the start of the regular session.
Sources
Mentioned: MRNA